Abstract 921: The value of cancer genomic data sharing

Abstract

Abstract Our understanding of and ability to combat cancer relies on the generation, analysis, and sharing of data. The Epidemiology and Genomics Research Program in the National Cancer Institute’s Division of Cancer Control and Population Sciences (DCCPS) has supported generation of large genomic data sets and advocated for and/or required broad sharing of this data. One of DCCPS’s scientific priorities is focused on data strategies namely, “the use, enhancement, expansion, and accessibility of new and existing DCCPS-supported data resources to accelerate cancer control research” (https://cancercontrol.cancer.gov/overview-highlights/2022/future_directions.html).EGRP funded the Genetic Associations and Mechanisms in Oncology (GAME-ON) Initiative, a multidisciplinary collaboration of researchers focused on understanding the genetic architecture, biology, and clinical and epidemiologic utility of common cancer risk variants. This program focused on 5 common cancer types - breast, colorectal, lung, ovarian, and prostate - and required research that incorporated multiple research domains and sharing of any data generated. A major accomplishment of this program was development of the OncoArray genotyping chip, which used information from genetic epidemiology studies, biological/functional analyses, and clinical and epidemiologic insights to create a comprehensive, high-density genotyping array for pan-cancer studies that has led to the discovery of hundreds of new cancer predisposition variants. This chip was used in a massive, coordinated genotyping effort that culminated in the generation of 7 datasets comprising genotyping data for nearly 500,000 individuals. All the data were deposited in dbGaP between 2014 and 2021 and are available (via controlled access) to any investigators. To understand the secondary use of these data, we determined the number of times the data had been downloaded, who downloaded the data, and types of research for which it was used. We also identified publications using OncoArray data and characterized the publications by research type, cancer type, and other details. Through this analysis, we explore how well the GAME-ON initiative and the OncoArray projects promote the DCCPS scientific priority of optimizing secondary research by making the data findable, accessible, interoperable, and reusable (FAIR). Citation Format: Stefanie Nelson, Charlisse Caga Anan, Elizabeth Gillanders. The value of cancer genomic data sharing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 921.